In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Acton Pharmaceuticals, Inc.

Latest From Acton Pharmaceuticals, Inc.

From Supertankers To Speedboats: Executives Make The Leap From Big Pharma To Start-Ups

Vir’s George Scangos, Westlake Village BioPartners’ Sean Harper, Kronos Bio’s Norbert Bischofberger, Scorpion’s Axel Hoos and Eikon’s Roy Baynes discuss the experiences they bring and the challenges they have faced in the transition from large drug makers to small biotechs. 

Leadership StartUps and SMEs

Mysterious Retro Biosciences Aims To Extend Human Lifespan By 10 Years With Cellular Anti-Aging Tech

Emerging from stealth mode, the Californian biotech aims to tackle aging processes looks to have some things in common with multi-billion dollar start up Altos.while also looking to legitimize the science of blood plasma transfusions.

Companies Clinical Trials

Korea's Cutting-Edge Biologics Law One Year On : What More Is Needed?

At a recent healthcare forum in Seoul, South Korea regenerative medicine industry executives and researchers discussed the current status of the sector, as well as what policy changes and support are needed to invigorate research, development and commercialization. 

South Korea Regenerative Medicine

Hal Barron Leaves GSK With A Stronger Pipeline But Still Awaiting Inflection

Research chief Barron is departing before his turnaround of GSK is fully realized but the consumer division spin-out could unlock new R&D money to help it challenge the sector’s leaders.

Companies Clinical Trials
See All

Company Information